<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01756365</url>
  </required_header>
  <id_info>
    <org_study_id>LOEX 015</org_study_id>
    <nct_id>NCT01756365</nct_id>
  </id_info>
  <brief_title>Autologous Cultured Corneal Epithelium (CECA) for the Treatment of Limbal Stem Cell Deficiency</brief_title>
  <acronym>CECA</acronym>
  <official_title>Autologous Cultured Corneal Epithelium ( Culture d'épithélium cornéen Autologue CECA) for the Treatment of Unilateral Corneal Lesions Associated With Limbal Stem Cell Deficiency</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>CHU de Quebec-Universite Laval</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>CHU de Quebec-Universite Laval</source>
  <brief_summary>
    <textblock>
      The study &quot; Autologous cultured corneal epithelium (CECA) for the treatment of corneal&#xD;
      lesions associated with limbal stem cell deficiency&quot; is the first clinical trial of this&#xD;
      product manufactured at the LOEX laboratory. The culture of corneal epithelium strives to&#xD;
      produce a reconstructed tissue with the therapeutical aim of treatment of limbal stem cell&#xD;
      deficiency. The study is a phase I/phase II study with the goal to evaluate safety and&#xD;
      efficacy of the CECA graft for the treatment of human patients suffering from limbal stem&#xD;
      cell deficiency.&#xD;
&#xD;
      The trial is open to all genders. The inclusion of 5 minors is planned.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2012</start_date>
  <completion_date type="Anticipated">December 2027</completion_date>
  <primary_completion_date type="Anticipated">December 2025</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Anatomic assessment</measure>
    <time_frame>1 year</time_frame>
    <description>Global severity score (Epithelial deficit, corneal opacity, peripheral and central vascularization, integrity of the ocular surface)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Best corrected visual acuity</measure>
    <time_frame>1 year</time_frame>
    <description>Evaluation according to Snellen chart</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>level of pain</measure>
    <time_frame>1 year</time_frame>
    <description>11 point numerical verbal scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>1 year</time_frame>
    <description>Health Utilities Index Mark 3</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">54</enrollment>
  <condition>Limbal Stem Cell Deficiency</condition>
  <arm_group>
    <arm_group_label>CECA</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>surgical transplantation of CECA</intervention_name>
    <arm_group_label>CECA</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        All genders&#xD;
&#xD;
          -  Adults&#xD;
&#xD;
          -  Minors&#xD;
&#xD;
          -  LSCD in one or two eyes. A minimum of 1-3 mm2 of undamaged limbus is required for a&#xD;
             biopsy to be taken without foreseeable adverse consequences for the donor eye&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Donor eye not sufficiently healthy to allow for the harvesting of a 1-3 mm2 limbal&#xD;
             biopsy without foreseeable consequences for the donor eye&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Breast-feeding&#xD;
&#xD;
          -  Incapacitated person&#xD;
&#xD;
          -  known allergy to aprotinine (Trasylol (R))&#xD;
&#xD;
          -  Hypersensibility to bovine proteins&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Year</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Richard Bazin, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU de Quebec</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Health Network - Toronto Western Hospital</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5T 2S8</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer Coleman</last_name>
      <phone>4163404800</phone>
      <phone_ext>5389</phone_ext>
    </contact>
    <investigator>
      <last_name>Allan Slomovic, BA, MA, MD, FRCSC</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CIUSSS de l'Est de l'île de Montréal</name>
      <address>
        <city>Montréal</city>
        <state>Quebec</state>
        <zip>H1T 2M4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dorline Sokoundjou, MSc</last_name>
      <phone>514-252-3400</phone>
      <phone_ext>7114</phone_ext>
      <email>bfv2.hmr@ssss.gouv.qc.ca</email>
    </contact>
    <investigator>
      <last_name>Isabelle Brunette, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre universitaire d'Ophtalmologie CHU de Québec - HSS</name>
      <address>
        <city>Québec</city>
        <zip>G1S 4L8</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Richard Bazin, MD FRCS (C)</last_name>
      <phone>418-682-7573</phone>
    </contact>
    <contact_backup>
      <last_name>Lucie Germain, PhD</last_name>
      <phone>4185254444</phone>
      <phone_ext>61696</phone_ext>
      <email>lucie.germain@fmed.ulaval.ca</email>
    </contact_backup>
    <investigator>
      <last_name>Richard Bazin, MD FRCS (C)</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>December 20, 2012</study_first_submitted>
  <study_first_submitted_qc>December 20, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 25, 2012</study_first_posted>
  <last_update_submitted>September 1, 2021</last_update_submitted>
  <last_update_submitted_qc>September 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>CHU de Quebec-Universite Laval</investigator_affiliation>
    <investigator_full_name>Richard Bazin</investigator_full_name>
    <investigator_title>Clinical professor ophtalmology, director of the cornea service</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

